+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; End User; and Country

  • ID: 5231379
  • Report
  • November 2020
  • Region: North America
  • 142 pages
  • The Insight Partners
UP TO OFF
until Jun 30th 2021
1 of 3

FEATURED COMPANIES

  • Abbott
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • MORE
According to a new market research study of ‘North America Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Analysis by product, and end-user’ the North America kidney disease market is expected to reach US$ 42,462.1 million in 2027 from US$ 25,483.5 in 2019. The market is estimated to grow with a CAGR of 6.7% from 2020-2027. The report provides trends prevailing in the North America kidney disease market and the factors driving market along with those that act as hindrances.

Based on the product, the North America the kidney disease market, is segmented into diagnosis and treatment. The diagnosis segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period. The Chronic kidney disease (CKD) can be diagnosed with blood and urine tests. Diagnosis of kidney disease is made with various tests such as blood tests, urine tests, imaging tests, and others. The tests must be performed in conditions such as diabetes, high blood pressure, heart disease, and a family history of kidney failure. Early kidney disease usually doesn’t have any symptoms. Testing is the only way to know how well kidneys are working.

The growth of the market is attributed to some key driving factors such as an increasing prevalence of chronic kidney related diseases and a high growth in aging population. However, the market is expected experiencing slow growth during the forecast period owing to failure in diagnosing cases of kidney diseases.

Abbott, Siemens AG, and F. Hoffmann-La Roche Ltd are among the leading companies operating in the North America kidney disease market.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America kidney diseasemarket.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America kidney disease market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth, offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Kidney Disease Market - by Product
1.3.2 Kidney Disease Market - by End User
1.3.3 North America Kidney Disease - by Country

2. North America Kidney Disease - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Kidney Disease - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Kidney Disease Market- North America PEST Analysis
4.3 Expert Opinion

5. North America Kidney Disease - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Kidney Related Diseases
5.1.2 High Growth in Aging Population
5.2 Market Restraints
5.2.1 Failure in Diagnosing Cases of Kidney Disease
5.3 Market Opportunities
5.3.1 A High Rise in Research & Development Regarding Kidney Diseases
5.4 Future Trends
5.4.1 Multiple Product Launches and Strategies
5.5 Impact Analysis

6. Kidney Disease Market - North America Analysis
6.1 North America Kidney Disease Revenue Forecasts and Analysis

7. North America Kidney Disease Analysis and Forecasts to 2027 - ByProduct
7.1 Overview
7.2 Kidney Disease Market Revenue Share, by Product (2019 and 2027)
7.3 Diagnosis
7.3.1 Overview
7.3.2 Diagnosis: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.3.3 Blood Tests
7.3.3.1 Overview
7.3.3.2 Blood Tests: Kidney Disease Market - Revenue and Forecast to 2027(US$ Million)
7.3.4 Urine Tests
7.3.4.1 Overview
7.3.4.2 Urine Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.3.5 Imaging Tests
7.3.5.1 Overview
7.3.5.2 Imaging Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.3.6 Others
7.3.6.1 Overview
7.3.6.2 Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Treatment
7.4.1 Overview
7.4.2 Treatment: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3 Drug Class
7.4.3.1 Overview
7.4.3.2 Drug Class: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.1 ACE Inhibitors
7.4.3.2.1.1 Overview
7.4.3.2.1.2 ACE Inhibitors: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.2 Angiotensin-II Receptor Blockers
7.4.3.2.2.1 Overview
7.4.3.2.2.2 Angiotensin-II Receptor Blockers: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.3 Diuretics
7.4.3.2.3.1 Overview
7.4.3.2.3.2 Diuretics: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.4 Others
7.4.3.2.4.1 Overview
7.4.3.2.4.2 Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.4 Dialysis
7.4.4.1 Overview
7.4.4.2 Dialysis: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.5 Others
7.4.5.1 Overview
7.4.5.2 Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)

8. North America Kidney Disease Analysis - by End-User
8.1 Overview
8.2 Kidney Disease Market Revenue Share, by End User (2019 and 2027)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Diagnostic Laboratories
8.4.1 Overview
8.4.2 Diagnostic Laboratories: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)

9. Kidney Disease Market Revenue and Forecasts to 2027 - Geographical Analysis
9.1 North America: Kidney Disease Market
9.1.1 Overview
9.1.2 North America: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.1.3.1 North America: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.3.2 North America: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.3.2.1 North America: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.4 North America: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.5 North America: Kidney Disease Market, by Country, 2019 & 2027 (%)
9.1.6 US: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.1.6.2.1 US: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.6.2.2 US: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.6.2.2.1 US: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.6.3 US: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.7 Canada: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.1 Canada: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2 Canada: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2.1 Canada: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.7.3 Canada: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.8 Mexico: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.1 Mexico: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.2 Mexico: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.2.1 Mexico: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.8.3 Mexico: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)

10. Impact Of COVID-19 Pandemic on North America Kidney Disease
10.1 North America: Impact Assessment of COVID-19 Pandemic

11. Company Profiles
11.1 Abbott
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 AbbVie Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Pfizer Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments

12. Appendix
12.1 About the Publisher
12.2 Glossary of terms

List of Tables
Table 1. North America: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 2. North America: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
Table 3. North America: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
Table 4. North America: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 5. North America: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 6. US: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 7. US: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
Table 8. US: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
Table 9. US: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 10. US: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 11. Canada: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 12. Canada: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
Table 13. Canada: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
Table 14. Canada: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 15. Canada: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 17. Mexico: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
Table 18. Mexico: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
Table 19. Mexico: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 20. Mexico: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 21. Glossary of Terms,Kidney disease

List of Figures
Figure 1. Kidney Disease Segmentation
Figure 2. North America Kidney Disease Overview
Figure 3. Diagnosis Segment Held Largest Share of Product in Kidney Disease Market
Figure 4. US is Expected to show Remarkable Growth during the Forecast Period
Figure 5. Kidney Disease Market - North America PEST Analysis
Figure 6. Kidney Disease Market Impact Analysis of Driver and Restraints
Figure 7. North America Kidney Disease - Revenue Forecasts and Analysis-2019-2027
Figure 8. Kidney Disease Market Revenue Share, by Product (2019 and 2027)
Figure 9. Diagnosis: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 10. Blood Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 11. Urine Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Imaging Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Treatment: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Drug Class: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. ACE Inhibitors: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Angiotensin-II Receptor Blockers: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 18. Diuretics: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Dialysis: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Kidney Disease Market Revenue Share, by End User (2019 and 2027)
Figure 23. Hospitals: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Diagnostic Laboratories: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. North America: Kidney Disease Market, by Key Country - Revenue (2019) (USD Million)
Figure 27. North America: Kidney Disease Market Revenue and Forecast to 2027 (USD Million)
Figure 28. North America: Kidney Disease Market, by Country, 2019 & 2027 (%)
Figure 29. US: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
Figure 30. Canada: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
Figure 31. Mexico: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in North American Country Markets
Note: Product cover images may vary from those shown
3 of 3
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • AbbVie Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc.
  • Amgen Inc.
  • Sysmex Corporation
  • Siemens AG
Note: Product cover images may vary from those shown
Adroll
adroll